Hospitals

Healthcare Leaders Reject Autonomous AI, Favor Hybrid Intelligence for Accuracy and Trust, New Survey Finds

Results show strong preference for AI paired with clinician oversight; concerns about "black box" risks persistSAN FRANCISCO, Dec. 16, 2025…

4 weeks ago

Penguin Location Services Announces Breakthrough RTLS 3.0 Platform and Expands Healthcare AI Capabilities for 2026

Next-Generation Real-Time Location System (RTLS) for Healthcare Delivers Enhanced Hospital Safety, Asset Tracking, and Patient Flow OrchestrationIRVINE, Calif., Dec. 16,…

4 weeks ago

Penguin Location Services Announces Breakthrough RTLS 3.0 Platform and Expands Healthcare AI Capabilities for 2026

Next-Generation Real-Time Location System (RTLS) for Healthcare Delivers Enhanced Hospital Safety, Asset Tracking, and Patient Flow OrchestrationIRVINE, Calif., Dec. 16,…

4 weeks ago

One Year After Go-Live, NOVO Hospital Confirms the Long-Term Value of Digital Pathology with Tribun Health

PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®, the digital pathology platform developed…

4 weeks ago

One Year After Go-Live, NOVO Hospital Confirms the Long-Term Value of Digital Pathology with Tribun Health

PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®, the digital pathology platform developed…

4 weeks ago

One Year After Go-Live, NOVO Hospital Confirms the Long-Term Value of Digital Pathology with Tribun Health

PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®, the digital pathology platform developed…

4 weeks ago

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full…

4 weeks ago

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full…

4 weeks ago

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full…

4 weeks ago

NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression

TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0),…

4 weeks ago